These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26414149

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study.
    D'Amico E, Chincoli C, Cacciatore P, di Pasqua G, Cosentino L, Riario-Sforza G, Pennese E, Capani F, Palazzi C.
    Dig Dis Sci; 2005 Dec; 50(12):2344-7. PubMed ID: 16416186
    [Abstract] [Full Text] [Related]

  • 4. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
    Fan XH, Wang LF, Liu LC, Yao Y, Shan Y, Lu HY, Wu CH, Xu XY, Wei L.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
    Cacoub P, Desbois AC, Isnard-Bagnis C, Rocatello D, Ferri C.
    J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Saadoun D, Resche Rigon M, Pol S, Thibault V, Blanc F, Pialoux G, Karras A, Bazin-Kara D, Cazorla C, Vittecoq D, Musset L, Peltier J, Decaux O, Ziza JM, Lambotte O, Cacoub P.
    J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
    [Abstract] [Full Text] [Related]

  • 10. New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir.
    McConachie SM, Wilhelm SM, Kale-Pradhan PB.
    Expert Rev Clin Pharmacol; 2016 Jan; 9(2):287-302. PubMed ID: 26651915
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
    Dammacco F, Lauletta G, Russi S, Leone P, Tucci M, Manno C, Monaco S, Ferrari S, Vacca A, Racanelli V.
    Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Chronic Hepatitis C in Special Populations.
    Bunchorntavakul C, Tanwandee T.
    Gastroenterol Clin North Am; 2015 Dec; 44(4):883-900. PubMed ID: 26600226
    [Abstract] [Full Text] [Related]

  • 14. Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis.
    De Nicola S, Aghemo A, Campise MR, D'Ambrosio R, Rumi MG, Messa P, Colombo M.
    Antivir Ther; 2014 Dec; 19(5):527-31. PubMed ID: 24009104
    [Abstract] [Full Text] [Related]

  • 15. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.
    Montalbano M, Pasulo L, Sonzogni A, Remuzzi G, Colledan M, Strazzabosco M.
    J Clin Gastroenterol; 2007 Feb; 41(2):216-20. PubMed ID: 17245223
    [Abstract] [Full Text] [Related]

  • 16. Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.
    Zampino R, Vitrone M, Parrella A, Ragone E, Durante-Mangoni E.
    J Chemother; 2018 Apr; 30(2):129-130. PubMed ID: 28925824
    [Abstract] [Full Text] [Related]

  • 17. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F, Cacoub P.
    Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
    [Abstract] [Full Text] [Related]

  • 18. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
    Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro G, Maso LD, Carniello G, Virgolini L, Tirelli U, Pozzato G.
    J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
    [Abstract] [Full Text] [Related]

  • 19. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P.
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
    Deming P, Martin MT, Chan J, Dilworth TJ, El-Lababidi R, Love BL, Mohammad RA, Nguyen A, Spooner LM, Wortman SB.
    Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.